Immune Checkpoint Inhibitor Use and Hospitalizations Near the End of Life

被引：0
|
作者：
Buzick, Justin [1 ]
Chang, He [1 ]
Shinkunas, Laura [2 ]
Glisch, Chad [3 ]
Lyckholm, Laurel [4 ]
Hagiwara, Yuya [2 ]
机构：
[1] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[2] Univ Iowa, Iowa City, IA 52242 USA
[3] Med Coll Wisconsin, Madison, WI USA
[4] West Virginia Univ, Sch Med, Richmond, VA USA
来源：
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2022年 / 63卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
GP721
引用
收藏
页码：1123 / 1123
页数：1
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitor Myopathy
    Beecher, Grayson
    Pinal-Fernandez, Iago
    Mammen, Andrew L.
    Liewluck, Teerin
    NEUROLOGY, 2024, 103 (11)
  • [32] The adoption of immune checkpoint inhibitors and patterns of care at the end of life.
    Riaz, Fauzia
    Gan, Geliang
    Li, Fangyong
    Davidoff, Amy J.
    Adelson, Kerin B.
    Presley, Carolyn J.
    Adamson, Blythe J. S.
    Shaw, Pooja
    Parikh, Ravi Bharat
    Mamtani, Ronac
    Gross, Cary Philip
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Immune Checkpoint Inhibitor Toxicity
    Palmieri, David J.
    Carlino, Matteo S.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [34] Immune checkpoint inhibitor myocarditis
    Raikhelkar, Jayant
    Uriel, Nir
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (03) : 303 - 306
  • [35] Effects of molecular targeting agents and immune-checkpoint inhibitors in patients with advanced cancer who are near the end of life
    Hiramoto, Shuji
    Taniyama, Tomohiko
    Kikuchi, Ayako
    Hori, Tetsuo
    Yoshioka, Akira
    Inoue, Akira
    PALLIATIVE & SUPPORTIVE CARE, 2021, 19 (06) : 709 - 714
  • [36] Immune Checkpoint Inhibitor Toxicity
    David J. Palmieri
    Matteo S. Carlino
    Current Oncology Reports, 2018, 20
  • [37] Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review
    Kitchlu, Abhijat
    Jhaveri, Kenar D.
    Ben Sprangers
    Yanagita, Motoko
    Wanchoo, Rimda
    CLINICAL KIDNEY JOURNAL, 2021, 14 (09) : 2012 - 2022
  • [38] Hyperprogressive Disease in Malignant Carcinoma With Immune Checkpoint Inhibitor Use: A Review
    Liu, Xiaojun
    Qiao, Liang
    FRONTIERS IN NUTRITION, 2022, 9
  • [39] Immune Checkpoint Inhibitor Treatment in Cancer: Immunomodulator Use and Evaluation by Rheumatology
    Cunningham-Bussel, Amy
    Wang, Jiaqi
    Prisco, Lauren C.
    Martin, Lily
    Gedmintas, Lydia
    Macfarlane, Lindsey
    Shadick, Nancy
    Awad, Mark
    Rahma, Osama
    LeBoeuf, Nicole
    Gravallese, Ellen
    Sparks, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [40] Successful use of an immune checkpoint inhibitor in a patient with myasthenia gravis in remission
    Jordan, Berit
    Zierz, Stephan
    Weber, Thomas
    Jordan, Karin
    MUSCLE & NERVE, 2019, 60 (01) : E7 - E8
12345